US2018338923A1PendingUtilityA1
Formulations for delivering insulin
Est. expiryApr 12, 2026(expired)· nominal 20-yr term from priority
Inventors:Halina LevchikMoses O. OyewumiShingai MajuruWilliam Elliott BayJun LiaoPuchun LiuSteven DinhNikhil Dhoot
A61K 9/2013A61K 9/2027A61K 9/2077A61K 9/2009A61K 9/2095A61K 9/145A61K 9/2063A61K 9/06A61K 38/28
61
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Oral insulin formulations and processes for preparing oral insulin formulations are provided.
Claims
exact text as granted — not AI-modified1 - 64 . (canceled)
65 . A solid dosage form wherein a delivery agent is lyophilized with insulin or an insulin analog.
66 . A solid dosage form wherein a delivery agent is rotary evaporated with insulin or an insulin analog.
67 . (canceled)
68 . A solid dosage form wherein a delivery agent and insulin or an insulin analog is in the form of a gel prior to being tableted or filled in a capsule.
69 . The solid dosage form of claim 68 comprising a gelatin.
70 . The compositions of any one of claim 65 wherein the delivery agent is 4-CNAB.
71 - 73 . (canceled)
74 . A process for preparing a solid dosage form of claim 65 comprising the steps of
(a) preparing an insulin/delivery agent solution;
(b) freeze-drying the insulin/delivery agent solution;
(c) milling the insulin/delivery agent colyophilized powder obtained by freeze-drying the insulin/delivery agent solution;
(d) mixing the milled co-lyophilized powder with intragranular excipients;
(e) performing dry granulation,
(f) adding extragranular excipients; and
(g) forming a unit dosage form from the resulting composition.
75 . A process for preparing a solid dosage form of claim 66 comprising the steps of
(a) preparing an insulin/delivery agent solution;
(b) performing rotary evaporation on the insulin/delivery agent solution; and
(c) forming a unit dosage form from the rotary evaporated insulin/delivery agent solution.
76 . The process of claim 75 further comprising at least one of the steps of (c) milling the insulin/delivery agent powder obtained by rotary evaporation of the insulin/delivery agent solution;
(d) mixing the milled powder with intragranular excipients;
(e) granulating the milled powder and intragranular excipients; and
(f) adding extragranular excipients.
77 . A process for preparing a solid dosage form of claim 68 comprising the step of mixing a gelling agent with (a) a delivery agent compound and (b) insulin or an insulin analog.
78 . The process of claim 77 wherein the gelling agent is gelatin.
79 . The process of any one of claim 77 wherein the delivery agent is 4-CNAB or a salt thereof.
80 . The process of claim 79 wherein the delivery agent is sodium 4-CNAB.
81 - 91 . (canceled)Join the waitlist — get patent alerts
Track US2018338923A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.